M&A Deal Summary

St. Jude Medical Acquires Endocardial Solutions

On January 13, 2005, St. Jude Medical acquired medical products company Endocardial Solutions from SightLine Partners for 272M USD

Acquisition Highlights
  • This is St. Jude Medical’s 5th transaction in the Medical Products sector.
  • This is St. Jude Medical’s 6th largest (disclosed) transaction.
  • This is St. Jude Medical’s 4th transaction in the United States.
  • This is St. Jude Medical’s 1st transaction in Minnesota.

M&A Deal Summary

Date 2005-01-13
Target Endocardial Solutions
Sector Medical Products
Buyer(s) St. Jude Medical
Sellers(s) SightLine Partners
Deal Type Add-on Acquisition
Deal Value 272M USD

Target

Endocardial Solutions

Saint Paul, Minnesota, United States
Endocardial Solutions, Inc. develops Minimally invasive technology for the diagnosis of abnormal heart rhythms.

Search 193,381 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

St. Jude Medical

Saint Paul, Minnesota, United States

website


Category Company
Founded 1976
Sector Medical Products
Employees18,000
Revenue 5.5B USD (2016)
DESCRIPTION
Entrance to St. Jude Medical's corporate headquarters in St. Paul, Minnesota.
Entrance to St. Jude Medical's corporate headquarters in St. Paul, Minnesota.

St. Jude Medical, Inc. is a medical device manufacturer dedicated to transforming the treatment of most expensive, epidemic diseases. St. Jude Medical five major areas of focus that include heart failure, atrial fibrillation, neuromodulation, traditional cardiac rhythm management and cardiovascular. St. Jude Medical was formed in 1976 and is based in St. Paul, Minnesota.


DEAL STATS #
Overall 5 of 18
Sector (Medical Products) 5 of 17
Type (Add-on Acquisition) 5 of 17
State (Minnesota) 1 of 3
Country (United States) 4 of 15
Year (2005) 1 of 3
Size (of disclosed) 6 of 14
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-10-07 Irvine Biomedical

Irvine, California, United States

Irvine Biomedical, Inc. (IBI) an Irvine, California, privately held company which develops electrophysiology (EP) catheter products that are used by physician specialists to diagnose and treat cardiac rhythm disorders.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-15 Velocimed

Maple Grove, Minnesota, United States

Velocimed, Inc. is a private company focused on the development of three novel cardiovascular devices.

Buy $74M

Seller(S) 1

SELLER

SightLine Partners

Bloomington, Minnesota, United States

Investor Investor Investor Investor

website


Category Growth Capital Firm
Founded 2004
Size Small
Type Sector Focused
DESCRIPTION

SightLine Partners is a private investment firm that targets early to late stage investments in growing healthcare and medical technology companies. Depending on the maturity of the company, Sightline will invest between $2 and $8 million per transaction. SightLine prefers US based opportunities. SightLine Partners LLC was formed in 2004 and is based in Minneapolis, Minnesota.


DEAL STATS #
Overall 7 of 16
Sector (Medical Products) 7 of 15
Type (Add-on Acquisition) 5 of 12
State (Minnesota) 2 of 5
Country (United States) 7 of 16
Year (2005) 1 of 1
Size (of disclosed) 2 of 7
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2004-10-08 FoxHollow Technologies

Redwood City, California, United States

FoxHollow Technologies, Inc. is a designer and manufacturer of medical devices primarily for the treatment of peripheral artery disease.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2005-02-16 Axya Medical

Beverly, Massachusetts, United States

Axya Medical, Inc. provides proprietary technology for the welding of surgical sutures and polymers for minimally invasive surgery and tissue approximation.

Buy -